S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial

Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare
No chart data

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
$2.50
-21.9%		$0.00
$0.15
▼
$1.37
$83.67MN/A842,200 shs34,486 shs
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/A0.00∞N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/A

Insider Ownership

CompanyInsider Ownership
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
3033.47 millionN/ANot Optionable

ARIX and APHB Headlines

SourceHeadline
Pacific Biosciences Stock (NASDAQ:PACB), Analyst Ratings, Price Targets, PredictionsPacific Biosciences Stock (NASDAQ:PACB), Analyst Ratings, Price Targets, Predictions
benzinga.com - October 24 at 10:52 PM
Aphb Colony Pin CodeAphb Colony Pin Code
indiatvnews.com - July 26 at 8:42 PM
Aphb Colony Moulali Pin CodeAphb Colony Moulali Pin Code
indiatvnews.com - February 26 at 7:37 AM
Akston Biosciences Strengthens Board with Addition of John T. PrestonAkston Biosciences Strengthens Board with Addition of John T. Preston
finance.yahoo.com - January 25 at 8:36 PM
Selecta Biosciences Stock (NASDAQ:SELB), Quotes and News SummarySelecta Biosciences Stock (NASDAQ:SELB), Quotes and News Summary
benzinga.com - January 5 at 5:43 PM
APHB: Case Study on AB-PA01 Presented at ISHLT Annual MeetingAPHB: Case Study on AB-PA01 Presented at ISHLT Annual Meeting
finance.yahoo.com - October 27 at 12:59 AM

Media Sentiment Over Time

Company Descriptions

Ampliphi Biosciences logo

Ampliphi Biosciences

NYSEAMERICAN:APHB
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.